Researchers discover new approach to make tumors sensitive to immunotherapy

Clinical Trials & Research

A cancer tumor’s ability to mutate allows it to escape from chemotherapy and other attempts to kill it. So, encouraging mutations would not be a logical path for cancer researchers. Yet a Mayo Clinic team and their collaborators took that counterintuitive approach and discovered that while it created resistance to chemotherapy, it also made tumors sensitive to immunotherapy. They also found that this approach worked successfully across tumor types and individual patient genomes. Their findings involving mouse models and human cells appear in Nature Communications.

The international team of researchers based in Rochester, Minn. and London, led by Richard Vile, Ph.D., a Mayo Clinic professor of pediatric oncology, studied models of both pediatric brain tumors and melanoma. They found that, in mice, high levels of the protein APOBEC3B drove a high rate of tumor mutations. Yet at the same time, these levels of APOBEC3B also sensitized cells to treatment with immune checkpoint blockade, a major mechanism of immunotherapy.

When you put that in the context of vaccine therapy, the mutations generate neoepitopes – a type of peptide that is a prime target for killer T cells. So that, combined with the checkpoint blockade, make for a potential cross-tumor therapy.”

Dr. Richard Vile, Mayo Clinic professor of pediatric oncology

The results showed a high rate of cures in subcutaneous melanoma and brain tumor models, and effectiveness no matter the tumor type or location. The results also showed that an individualized approach for each patient is not required. The team are hoping to translate this work into clinical trials for pediatric brain tumors within the next year.

Products You May Like

Articles You May Like

New tool can employ MRI scan data to predict motor development risks for preterm infants
Fewer than 10% of Americans show signs of past coronavirus infection, study finds
‘Schoolcations’ are trying to lure parents who have had it with remote learning
Companies will have to ‘seduce’ staff to go back to the office, real estate CEO says
CDC extends ban on cruising through October after White House reportedly overrules longer extension

Leave a Reply

Your email address will not be published. Required fields are marked *